Navigation Links
MammaPrint Breast Cancer Diagnostic Test

ProductsMammaPrint Breast Cancer Diagnostic Test
Company Agendia Corporate
Item MammaPrint Breast Cancer Diagnostic Test
Features 
  • Industry quality microarrays: Agendia uses customized DNA microarrays, manufactured by Agilent (one of the world's leading suppliers of microarray products).
  • Specimen processing: A review of specimen histology and RNA quality is carried out prior to microarray analysis to confirm test suitability.
  • Test confidence: Triplicate gene expression measurements and also duplicate sample measurements, incorporating a dye-swap step.
  • Test consistency: Each patient sample is tested using a constant, standardized reference, normalized to a constant set of breast cancer specific normalization genes.
Description MammaPrint is a gene expression profiling test that predicts the risk of metastasis in breast cancer patients. It is based on groundbreaking research performed at the Netherlands Cancer Institute and the Antoni Van Leeuwenhoek Hospital in Amsterdam, The Netherlands.
Info Agendia Corporate
Customer Service: +31 20 512 9161
Web site: http://www.agendia.com/

Related medicine products :

1. Breast Cancer Camera
2. Breast Overlay
3. Breast Biopsy Guard
4. Multi Frequency Linear Breast Transducer UST-5539-7.5
5. Multi Frequency Linear Breast HST Transducer UST-5542
6. Multi Frequency Linear Breast HST Transducer UST-5543
7. Multi Frequency Linear Breast Transducer
8. Smooth Round Moderate Plus Profile Breast Implant
9. Smooth Round Moderate Profile Breast Implant
10. Elite™ Gels Round Moderate Breast Implant
11. Elite™ Gels Round High Profile Breast Implant
Bra With Cups...
Bras and Breast Support...
... (ACB®) Test is a clinical chemistry assay ... measuring the cobalt binding capacity of albumin ... in the early 1990s, IMA is produced ... ischemic tissue in the heart. During ischemia, ...
... The Albumin Cobalt Binding (ACB®) Test ... Ischemia Modified Albumin (IMA®) by measuring the ... patient serum sample. First identified in the ... albumin comes in contact with ischemic tissue ...
Medicine Products:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The American ... to become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer ... Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the Law ... organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our ... a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... of 2017 on Tuesday, October 24, 2017. Lilly will ... the investment community and media to further detail the ... begin at 9 a.m. Eastern time. Investors, media and ... the conference call through a link that will be ...
(Date:10/2/2017)... announces the European launch of their new low volume, high throughput ... Cambridge, U.K on October 4th. The new ... unprecedented speed and sensitivity while using far less sample volume through ... ... ...
(Date:9/28/2017)... CHICAGO , Sept. 28, 2017 Hill-Rom ... quarter 2017 earnings conference call and webcast on Friday, ... 8:00 a.m. (EDT) and ending at approximately 8:30 a.m. ... to discussing the company,s 2017 financial performance and guidance ... growth opportunities, initiatives to enhance operational performance, and long-range ...
Breaking Medicine Technology: